Viking Therapeutics (VKTX) is back in focus after its latest quarterly report showed a wider net loss, a development that immediately reframed how traders and longer term investors assess the biotech’...
Source LinkViking Therapeutics (VKTX) is back in focus after its latest quarterly report showed a wider net loss, a development that immediately reframed how traders and longer term investors assess the biotech’...
Source Link
Comments